Ads
related to: bristol-myers squibb- Savings Card
See If You Are Eligible To Save
On An ELIQUIS Prescription
- Chat With Elise
Get Help From Our
Virtual Assistant, Elise
- ELIQUIS & Safety Info
See Full Safety Info &
Boxed Warning. Learn More
- Prescribing Info
See Full Prescribing Info
Including Boxed Warning
- ELIQUIS HCP Info
Visit the Official US Healthcare
Website for ELIQUIS Safety Info
- Doctor Discussion Guide
Learn More About The Interactive
Eliquis Doctor Discussion Guide
- Savings Card
scbn.org has been visited by 10K+ users in the past month
Search results
Q2 2025 Earnings Estimate for Bristol-Myers Squibb Issued By Zacks Research (NYSE:BMY)
ETF DAILY NEWS· 13 hours agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Investment analysts at Zacks Research raised their Q2 2025 earnings estimates for shares of Bristol-Myers Squibb in a research report issued on ...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
ETF DAILY NEWS· 3 days agoShares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...
Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
Simply Wall St. via Yahoo Finance· 5 days agoWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to...
Bristol Myers, Sanofi Liability in Hawaii Plavix Case Grows to $916 Million
Insurance Journal· 5 days agoA judge in Hawaii on Tuesday ordered Bristol Myers Squibb and Sanofi to pay more than $916 million...
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income...
Morningstar· 6 days agoBristol Myers Squibb (NYSE: BMY) today announced ASPIRE (Accessibility, Sustainability, Patient-centric, Impact, Responsibility and Equity), a 10-year strategy to advance access to our innovative ...
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology...
Morningstar· 5 days agoBristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend...
Benzinga· 2 hours agoLoading... Loading... During times of turbulence and uncertainty in the markets, even when markets...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 2 hours agoUS-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its...
This Unpopular Dividend Stock Is a Buy
The Motley Fool via AOL· 5 days agoDividend stocks are an important anchor for well-balanced portfolios. Regular cash distributions can buffer a portfolio against market volatility and...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 7 hours agoThis week on Pipeline Moves, we kick off by looking at a Phase III trial of GlycoMimetics’...